You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Respiratory Syncytial Viruses

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe

Not yet recruiting
  • Respiratory Syncytial Viruses
  • Prior standard of care receipt of Pfizer's ABRYSVO vaccine
  • (no location specified)
Oct 5, 2023

Respiratory Syncytial Viruses Trial in London (MK-1654, Placebo, RSV-A Memphis 37b)

Completed
Has Results
  • Respiratory Syncytial Viruses
  • Clesrovimab
  • +2 more
  • London, United Kingdom
    HVIVO Services Ltd ( Site 0001)
Aug 29, 2022

Respiratory Syncytial Viruses Trial (sisunatovir, Placebo)

Not yet recruiting
  • Respiratory Syncytial Viruses
  • (no location specified)
Jan 25, 2023

Respiratory Syncytial Virus (RSV), Respiratory Viral Infection, Acute Disease Trial in Izumo, Kyoto, Nara

Not yet recruiting
  • Respiratory Syncytial Virus (RSV)
  • +2 more
    • Izumo, Shimane, Japan
    • +2 more
    Jun 13, 2023

    Infectious Disease, Influenza, Respiratory Syncytial Virus (RSV) Trial in Lørenskog (Stop antibiotic therapy)

    Recruiting
    • Infectious Disease
    • +3 more
    • Stop antibiotic therapy
    • Lørenskog, Norway
      Akershus University Hospital
    Jun 15, 2022

    Respiratory Syncytial Viruses Trial in Australia (RSV F Vaccine with Aluminum Phosphate Adjuvant, RSV F Vaccine, Matrix-M1

    Completed
    • Respiratory Syncytial Viruses
    • RSV F Vaccine with Aluminum Phosphate Adjuvant
    • +3 more
    • Sydney, New South Wales, Australia
    • +4 more
    Dec 2, 2021

    Respiratory Syncytial Viruses Trial in Canada, United Kingdom, United States (RSVPreF3 OA investigational vaccine, HZ/su

    Not yet recruiting
    • Respiratory Syncytial Viruses
    • RSVPreF3 OA investigational vaccine
    • HZ/su vaccine
    • Daphne, Alabama
    • +23 more
    Jul 21, 2023

    Respiratory Syncytial Virus Infections Trial in Belgium, Canada, United States (RSVPreF3 formulation 3, RSVPreF3 formulation 2,

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 formulation 3
    • +4 more
    • Miami, Florida
    • +7 more
    Nov 12, 2021

    Influenza, Human Prevention, Respiratory Syncytial Viruses Prevention Trial in United States (Ad26.RSV.preF-based vaccine,

    Completed
    • Influenza, Human Prevention
    • Respiratory Syncytial Viruses Prevention
    • Ad26.RSV.preF-based vaccine
    • +2 more
    • Long Beach, California
    • +18 more
    Oct 25, 2022

    Respiratory Syncytial Virus Disease in Infants and Toddlers

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
      • (no location specified)
      Jul 27, 2023

      Respiratory Tract Infections Trial (Respiratory pathogen panel PCR test, COVID-19 antibody test)

      Not yet recruiting
      • Respiratory Tract Infections
      • Respiratory pathogen panel PCR test
      • COVID-19 antibody test
      • (no location specified)
      May 8, 2023

      Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)

      Active, not recruiting
      • Respiratory Syncytial Virus Infections
      • RSV/Flu-01E low dose
      • +2 more
      • Saint Petersburg, Russian Federation
        Smorodintsev Research Institute of Influenza
      Jul 24, 2023

      Respiratory Viral Infection, SARS CoV 2 Infection Trial in Banjul

      Active, not recruiting
      • Respiratory Viral Infection
      • SARS CoV 2 Infection
        • Banjul, Western Region, Gambia
          Field study in the West Coast Region and Kanifing Municipality C
        Jul 11, 2023

        Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)

        Not yet recruiting
        • Respiratory Syncytial Virus Infection
        • (no location specified)
        Oct 6, 2023

        Respiratory Syncytial Virus (RSV) Trial in London (RV299, Placebo)

        Completed
        • Respiratory Syncytial Virus (RSV)
        • London, United Kingdom
          Pfizer
        Oct 5, 2023

        Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV) Trial in Ha Noi (0.9% NaCl physiological

        Recruiting
        • Acute Respiratory Tract Infections
        • +2 more
        • 0.9% NaCl physiological saline
        • LiveSpo Navax
        • Ha Noi, Vietnam
          The Center for Pulmonology and Respiratory Care, Vietnam Nationa
        Jul 4, 2023

        RESCEU: Defining the Burden of RSV Disease

        Active, not recruiting
        • Respiratory Syncytial Virus Infections
        • RSV Infection
        • venepuncture
        • nasopharyngeal swab
        • Oxford, Oxfordshire, United Kingdom
          University of Oxford
        Oct 25, 2022

        Respiratory Syncytial Virus Infections Trial (Placebo, Active)

        Not yet recruiting
        • Respiratory Syncytial Virus Infections
        • (no location specified)
        Oct 20, 2023

        Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus Trial in Rolling Hills Estates, Miami,

        Recruiting
        • Respiratory Syncytial Virus Infection
        • +2 more
        • RSV/hMPV vaccine candidate Dose L
        • +3 more
        • Rolling Hills Estates, California
        • +2 more
        Nov 14, 2023

        Respiratory Syncytial Virus Infections Trial in Adelaide (Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /,

        Active, not recruiting
        • Respiratory Syncytial Virus Infections
        • Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /placebo
        • +2 more
        • Herston, Queensland, Australia
        • +1 more
        Feb 1, 2023

        Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

        Terminated
        • Respiratory Syncytial Virus Infections
        • Influenza, Human
        • RSV A Memphis 37
        • Influenza A/California/04/2009
        • London, United Kingdom
          National Heart and Lung Institute, Imperial College London
        Jun 23, 2022

        Respiratory Syncytial Virus Trial in Panama, United States (mRNA-1345, Placebo)

        Not yet recruiting
        • Respiratory Syncytial Virus
        • mRNA-1345
        • Placebo
        • Banning, California
        • +20 more
        Oct 18, 2023

        Respiratory Viral Infection, Common Cold, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Vienna (nasal spray)

        Completed
        • Respiratory Viral Infection
        • +4 more
        • nasal spray
        • Vienna, Austria
        • +1 more
        Aug 24, 2022

        Burden of Respiratory Syncytial Virus in Sweden: A Retrospective

        Active, not recruiting
        • Respiratory Syncytial Virus (RSV)
          • (no location specified)
          Nov 10, 2022

          Respiratory Syncytial Virus Infections Trial in United States (AZM Group, Control Group)

          Recruiting
          • Respiratory Syncytial Virus Infections
          • AZM Group
          • Control Group
          • Birmingham, Alabama
          • +4 more
          Jun 16, 2022